Skip to content

Nutritional Strategy for Blood Pressure Control in Patients With Hypertension (NUPRESS)

Effectiveness of a Nutritional Strategy for Blood Pressure Control in Patients With Hypertension Users of a Public Health System: NUPRESS Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03793881
Enrollment
408
Registered
2019-01-04
Start date
2019-04-24
Completion date
2022-12-30
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Adherence to a healthy dietary pattern is part of the self-care of patients with hypertension, and may contribute substantially to therapeutic target goals as well as to a better quality of life. However, not all nutritional recommendations aimed at these patients are easily applicable in clinical practice. The primary objective of the study is to evaluate the effectiveness of a nutritional strategy for blood pressure control in patients with hypertension users of a Public Health System after 6 months of follow-up. As secondary objectives, we will evaluate the impact of the proposed strategy on self-care and on the quality of life of the patients. In this multicenter open-label randomized trial, 408 patients ≥21 years old with hypertension, systolic blood pressure (SBP) ≥140mmHg at the moment of the screening and who have not received or received nutritional counseling for at least 06 months will be enrolled. Patients allocated to the control group will receive individualized dietary prescription according to the guidelines of the Brazilian Society of Cardiology. Nutritional counseling in the intervention group will be performed based on the quality of the diet, the Food Guide for the Brazilian Population and concepts of mindfulness and mindful eating; all dietary guidance will be based on feasible goals built together (patient and nutritionist), and no diet will be prescribed for intervention group. In both groups, patients will receive automatic monitors for residential self-monitoring blood pressure. On-site follow-up visits will be carried out at 30, 60, 90, and 180 days (final consultation). At 120 and 150 days, participants in the intervention group will receive motivational messages via e-mail or SMS (for these patients, consultation of 30 days will be a group meeting). Laboratory tests (lipid and glycemic profile, serum creatinine, serum sodium, urinary sodium, serum potassium, urinary potassium and albuminuria) will be performed at baseline and 180 days; anthropometric indexes and diastolic blood pressure (DBP) will be also evaluated.

Interventions

Counseling based on dietary goals and mindfulness techniques.

Dietary prescription according to guidelines.

Sponsors

Hospital do Coracao
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

≥21 years old with medical diagnosis of hypertension, systolic blood pressure (SBP) ≥140 mmHg at the moment of the screening and who have not received or received nutritional counseling for at least 06 months.

Exclusion criteria

* Diagnosis of resistant and/or secondary hypertension; * Severe neuropathy; * Chronic kidney disease; * Active cancer or life expectancy \<6 months; * Chemical dependence or use of antipsychotic drugs; * Autoimmune disease or chronic use of steroids; * Pregnancy and lactation; * Acute coronary syndrome in the last 60 days; * Severe or unstable heart failure; * Wheelchair users; * Extreme obesity (body mass index \[BMI\] ≥40kg / m²); * Cognitive, neurological or psychiatric condition that prevents participation in the study; * Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
SBP6 monthsSystolic blood pressure, in mmHg
BPC6 monthsBlood pressure control, defined as either having systolic blood pressure (SBP) \> 140 mmHg at baseline and achieving SBP ≤ 140 mmHg after follow-up or having SBP ≤ 140 mmHg at baseline and reducing anti-hypertensive drugs after follow-up.

Secondary

MeasureTime frameDescription
HbA1C6 monthsGlycated hemoglobin, in %
FG6 monthsFasting glucose, in mg/dL
BW6 monthsBody weight, in kg
WC6 monthsWaist circumference, in cm
BMI6 monthsBody mass index, in kg/m2; it will be defined according to the mathematical formula (BW/height\*height)
TC6 monthsTotal cholesterol, in mg/dL
LDL-c6 monthsLDL cholesterol, in mg/dL; it will be defined according to the Martin´s mathematical formula
HDL-c6 monthsHDL cholesterol, in mg/dL
TG6 monthsSerum triglycerides, in mg/dL
VLDL-c6 monthsVLDL cholesterol, in mg/dL; it will be obtained according to the mathematical formula TG/5
NHDL6 monthsNon-HDL cholesterol, in mg/dL; it will be obtained according to the mathematical formula TC-HDL-c
Castelli Index II6 monthsCastelli Index II, in mg/dL; it will be obtained according to the mathematical formula LDL-c/HDL-c
Cr6 monthsCreatinine, in mg/dL
GFR6 monthsGlomerular filtration rate, in ml/min/1.73m2
Sodium (s)6 monthsSerum sodium, in mEq/L
Sodium (u)6 monthsUrinary sodium, in mEq/L
Potassium (s)6 monthsSerum potassium, in mEq/L
Potassium (u)6 monthsUrinary potassium, in mEq/L
ALB6 monthsAlbuminuria, in mg/g
DQ6 monthsDiet quality, assessed by the modified Alternative Healthy Eating Index (mAHEI)
MINICHAL6 monthsQuality of life evaluated by the Brazilian version of the Mini-cuestionario de calidad de vida en la hipertensión arterial. In this tool, ten items are related to the mental status domain and six items to somatic manifestations. Questions refer to the past seven days. The score scale is a likert-type scale with four possible answers (0=absolutely no; 1=yes, a little; 2=yes, fairly; 3=yes, a lot). The points range from 0 (best health level) to 30 (worst health level) for the mental status dimension, and from 0 (best health level) to 18 (worst health level) for the somatic manifestations dimension.
SHIQ6 monthsSelf-care evaluated by the Brazilian version of the Self-care of Hypertension Inventory Questionaire. This tool includes 23 items divided across 3 scales: Self-care Maintenance (11 items), Self-care Management (6 items), and Self-care Confidence (6 items). Items in the instrument are scored on a Likert-type scale. In the Self-care Maintenance domain, scores range from 1 to 5 (''never'' to ''always''). In the Self-care Management domain, 2 items range from 0 to 5 to capture a fully negative response, and other item options are scored 1 to 5. The remaining items are scored from 1 to 5 (''not likely'' to ''very likely''). In the self-care confidence scale, items are scored from 1 to 5. Scores are calculated for each scale individually. Each scale is standardized to range from 0 to 100. Self-care is considered adequate if the score is 70 or greater.
Castelli Index I6 monthsCastelli Index I, in mg/dL; it will be obtained according to the mathematical formula TC/HDL-c
DBP6 monthsDiastolic blood pressure, in mmHg

Other

MeasureTime frameDescription
TT6 monthsTherapeutic targets, defined as the proportion of participants who reached the following therapeutic targets: SBP/DBP \< 140/90 mmHg; fasting glucose \<100 mg/dL; LDL-c \<100 mg/dL; BMI \< 25 kg/m2 or weight loss \> 5%
AHD6 monthsAnti-hypertensive drugs, defined as the type and proportion of anti-hypertensive drugs used

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 3, 2026